Takeda sues Taiyo over product recalls
This article was originally published in Scrip
Executive Summary
Takedahas filed a lawsuit seeking ¥2.8 billion ($26.9 million) in damages from fellow Japanese firm Taiyo Pharmaceutical Industry in relation to the contract manufacture of an injectable antibiotic. Two lots of Pansporin (cefotiam) made by Taiyo were recalled last year following the discovery of glass fragments in two vials. In an action brought with the Osaka district court, Takeda said it was seeking the damages for insufficient quality control procedures and record keeping with regard to the identification of potentially defective products. Takeda noted that the suit followed the failure of direct negotiations with Taiyo and that all of its injectable antibiotics were now made at an in-house plant in Japan.